ATRX (D5)

The ATRX (D5) test targets the ATRX gene, commonly mutated in various tumors like gliomas and neuroblastomas. ATRX mutations are associated with poor prognosis and specific tumor characteristics. This test is critical for understanding the molecular profile of certain cancers.

Also known asIhc - Atrx (d5) Ihc - Atrx (d5)

Available via

Home Collection, Lab Visit

Contains

3 parameters

Earliest reports in

3 Working Days

Test details

ATRX (D5) Test in Bengaluru Overview

Preparations

No special preparations needed

Test included
ATRX (D5) includes 3 parameters

  • Request Letter
  • Additional Communication
  • Atrx (d5)
Frequently Asked Questions

The ATRX D5 Test detects alterations in the ATRX gene, commonly associated with alpha-thalassemia and intellectual disabilities.

Patients with developmental delays, suspected genetic syndromes, or alpha-thalassemia should undergo this test.

A blood or tissue sample is analyzed using fluorescence in situ hybridization (FISH) or PCR to detect ATRX gene mutations.

Positive results suggest mutations in the ATRX gene, necessitating genetic counseling and further evaluation.

Genetic counseling and targeted therapies may be recommended for managing associated symptoms and complications.

Test code

Z413K

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Paraffin BlockOthers100 MG
TissueOthers10

Specimen stability information

Paraffin Block, Tissue

Collection instructions

Site Of Biopsy Specimen + Clinical Details. Relevant Radiology Findings: X-Ray/Ct/Mri Report Images (Soft Copy). If tissue received, tissue processing will be charged.

Specimen rejection criteria

Test run frequency

Every Day TIME - 08:00

Turn around time

3 Working Days

Performing locations

Department

  • Histopath

CPT and Loinc codes

ATRX (D5)

2100